title: Protracted Lhermitte Sign After Cisplatin and Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
authors.affiliation: College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
authors.forename: Tyler
authors.initials: T
authors.lastname: Gutschenritter
authors.affiliation: Department of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
authors.forename: Chance
authors.initials: C
authors.lastname: Matthiesen
authors.affiliation: Hematology/Oncology Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
authors.forename: Mohammad
authors.initials: M
authors.lastname: Razaq
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D059248:Chemoradiotherapy / Q000009:adverse effects / Q000379:methods; D002945:Cisplatin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077274:Nasopharyngeal Carcinoma / Q000628:therapy*; D009303:Nasopharyngeal Neoplasms / Q000628:therapy*; D010292:Paresthesia / Q000175:diagnosis / Q000209:etiology*; D011879:Radiotherapy Dosage; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects*
chemical_list: D002945:Cisplatin